These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 33001586)

  • 1. Dissecting the Cellular Mechanism of Prostacyclin Analog Iloprost in Reversing Vascular Dysfunction in Scleroderma.
    Tsou PS; Palisoc PJ; Flavahan NA; Khanna D
    Arthritis Rheumatol; 2021 Mar; 73(3):520-529. PubMed ID: 33001586
    [TBL] [Abstract][Full Text] [Related]  

  • 2. VE-cadherin trans-interactions modulate Rac activation and enhancement of lung endothelial barrier by iloprost.
    Birukova AA; Tian Y; Dubrovskyi O; Zebda N; Sarich N; Tian X; Wang Y; Birukov KG
    J Cell Physiol; 2012 Oct; 227(10):3405-16. PubMed ID: 22213015
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Superoxide inhibition restores endothelium-dependent dilatation in aging arteries by enhancing impaired adherens junctions.
    Chang F; Flavahan S; Flavahan NA
    Am J Physiol Heart Circ Physiol; 2018 Apr; 314(4):H805-H811. PubMed ID: 29351453
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impaired activity of adherens junctions contributes to endothelial dilator dysfunction in ageing rat arteries.
    Chang F; Flavahan S; Flavahan NA
    J Physiol; 2017 Aug; 595(15):5143-5158. PubMed ID: 28561330
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Atorvastatin enhances endothelial adherens junctions through promoting VE-PTP gene transcription and reducing VE-cadherin-Y731 phosphorylation.
    Huo Z; Kong Y; Meng M; Cao Z; Zhou Q
    Vascul Pharmacol; 2019 Jun; 117():7-14. PubMed ID: 29894844
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Endothelial barrier stabilization by a cyclic tandem peptide targeting VE-cadherin transinteraction in vitro and in vivo.
    Heupel WM; Efthymiadis A; Schlegel N; Müller T; Baumer Y; Baumgartner W; Drenckhahn D; Waschke J
    J Cell Sci; 2009 May; 122(Pt 10):1616-25. PubMed ID: 19420236
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Incorporation of iloprost in phospholipase-resistant phospholipid scaffold enhances its barrier protective effects on pulmonary endothelium.
    Oskolkova O; Sarich N; Tian Y; Gawlak G; Meng F; Bochkov VN; Berdyshev E; Birukova AA; Birukov KG
    Sci Rep; 2018 Jan; 8(1):879. PubMed ID: 29343759
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CMTM3 (CKLF-Like Marvel Transmembrane Domain 3) Mediates Angiogenesis by Regulating Cell Surface Availability of VE-Cadherin in Endothelial Adherens Junctions.
    Chrifi I; Louzao-Martinez L; Brandt M; van Dijk CGM; Burgisser P; Zhu C; Kros JM; Duncker DJ; Cheng C
    Arterioscler Thromb Vasc Biol; 2017 Jun; 37(6):1098-1114. PubMed ID: 28428220
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Selective targeting of angiogenic tumor vasculature by vascular endothelial-cadherin antibody inhibits tumor growth without affecting vascular permeability.
    Liao F; Doody JF; Overholser J; Finnerty B; Bassi R; Wu Y; Dejana E; Kussie P; Bohlen P; Hicklin DJ
    Cancer Res; 2002 May; 62(9):2567-75. PubMed ID: 11980651
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential regulation of endothelial cell permeability by high and low doses of oxidized 1-palmitoyl-2-arachidonyl-sn-glycero-3-phosphocholine.
    Starosta V; Wu T; Zimman A; Pham D; Tian X; Oskolkova O; Bochkov V; Berliner JA; Birukova AA; Birukov KG
    Am J Respir Cell Mol Biol; 2012 Mar; 46(3):331-41. PubMed ID: 21997484
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sphingosine 1-Phosphate Receptor 1 Signaling Maintains Endothelial Cell Barrier Function and Protects Against Immune Complex-Induced Vascular Injury.
    Burg N; Swendeman S; Worgall S; Hla T; Salmon JE
    Arthritis Rheumatol; 2018 Nov; 70(11):1879-1889. PubMed ID: 29781582
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human mesenchymal stem cells inhibit vascular permeability by modulating vascular endothelial cadherin/β-catenin signaling.
    Pati S; Khakoo AY; Zhao J; Jimenez F; Gerber MH; Harting M; Redell JB; Grill R; Matsuo Y; Guha S; Cox CS; Reitz MS; Holcomb JB; Dash PK
    Stem Cells Dev; 2011 Jan; 20(1):89-101. PubMed ID: 20446815
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oral iloprost treatment in patients with Raynaud's phenomenon secondary to systemic sclerosis: a multicenter, placebo-controlled, double-blind study.
    Wigley FM; Korn JH; Csuka ME; Medsger TA; Rothfield NF; Ellman M; Martin R; Collier DH; Weinstein A; Furst DE; Jimenez SA; Mayes MD; Merkel PA; Gruber B; Kaufman L; Varga J; Bell P; Kern J; Marrott P; White B; Simms RW; Phillips AC; Seibold JR
    Arthritis Rheum; 1998 Apr; 41(4):670-7. PubMed ID: 9550476
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PKCα activation of p120-catenin serine 879 phospho-switch disassembles VE-cadherin junctions and disrupts vascular integrity.
    Vandenbroucke St Amant E; Tauseef M; Vogel SM; Gao XP; Mehta D; Komarova YA; Malik AB
    Circ Res; 2012 Aug; 111(6):739-49. PubMed ID: 22798526
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Histone Deacetylase 5 Is Overexpressed in Scleroderma Endothelial Cells and Impairs Angiogenesis via Repression of Proangiogenic Factors.
    Tsou PS; Wren JD; Amin MA; Schiopu E; Fox DA; Khanna D; Sawalha AH
    Arthritis Rheumatol; 2016 Dec; 68(12):2975-2985. PubMed ID: 27482699
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of long-term cyclic iloprost therapy in systemic sclerosis with Raynaud's phenomenon. A randomized, controlled study.
    Scorza R; Caronni M; Mascagni B; Berruti V; Bazzi S; Micallef E; Arpaia G; Sardina M; Origgi L; Vanoli M
    Clin Exp Rheumatol; 2001; 19(5):503-8. PubMed ID: 11579708
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Endothelial-to-mesenchymal transition contributes to endothelial dysfunction and dermal fibrosis in systemic sclerosis.
    Manetti M; Romano E; Rosa I; Guiducci S; Bellando-Randone S; De Paulis A; Ibba-Manneschi L; Matucci-Cerinic M
    Ann Rheum Dis; 2017 May; 76(5):924-934. PubMed ID: 28062404
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Practical suggestions on intravenous iloprost in Raynaud's phenomenon and digital ulcer secondary to systemic sclerosis: Systematic literature review and expert consensus.
    Ingegnoli F; Schioppo T; Allanore Y; Caporali R; Colaci M; Distler O; Furst DE; Hunzelmann N; Iannone F; Khanna D; Matucci-Cerinic M
    Semin Arthritis Rheum; 2019 Feb; 48(4):686-693. PubMed ID: 29706243
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enhanced endothelial barrier function by monoclonal antibody activation of vascular endothelial cadherin.
    Park KS; Schecterson L; Gumbiner BM
    Am J Physiol Heart Circ Physiol; 2021 Apr; 320(4):H1403-H1410. PubMed ID: 33577432
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Iloprost for the treatment of systemic sclerosis].
    Hachulla E; Launay D; Hatron PY
    Presse Med; 2008 May; 37(5 Pt 2):831-9. PubMed ID: 18035518
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.